XML 53 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Basis of Presentation and Summary of Significant Accounting Policies (Textual) (Details) (USD $)
12 Months Ended
Dec. 31, 2014
operating_segment
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Advertising        
Advertising Expense $ 300,000us-gaap_AdvertisingExpense $ 500,000us-gaap_AdvertisingExpense $ 400,000us-gaap_AdvertisingExpense  
Cash, Cash Equivalents and Marketable Securities [Abstract]        
Cash and cash equivalents 26,487,000us-gaap_CashAndCashEquivalentsAtCarryingValue 22,130,000us-gaap_CashAndCashEquivalentsAtCarryingValue 32,003,000us-gaap_CashAndCashEquivalentsAtCarryingValue 25,762,000us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash 11,900,000us-gaap_Cash 6,000,000us-gaap_Cash    
Available-for-sale securities 15,165,000us-gaap_AvailableForSaleSecuritiesAmortizedCost 19,654,000us-gaap_AvailableForSaleSecuritiesAmortizedCost    
Intangible Assets, Net (Excluding Goodwill) [Abstract]        
Tangible Asset Impairment Charges 1,841,000us-gaap_PropertyPlantAndEquipmentTransfersAndChanges 0us-gaap_PropertyPlantAndEquipmentTransfersAndChanges    
Impairment of Intangible Assets, Finite-lived 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived      
Number of Operating Segments 1us-gaap_NumberOfOperatingSegments      
Goodwill impairment 0us-gaap_GoodwillImpairmentLoss 0us-gaap_GoodwillImpairmentLoss    
Core IP [Member]        
Intangible Assets, Net (Excluding Goodwill) [Abstract]        
Undiscounted cash flows, discount rate (percent)   19.50%us-gaap_FairValueInputsDiscountRate
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
18.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
 
Undiscounted cash flows, long-term growth rate (percent)   2.00%us-gaap_FairValueInputsLongTermRevenueGrowthRate
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
2.00%us-gaap_FairValueInputsLongTermRevenueGrowthRate
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
 
Percentage of undiscounted cash flows per product (percent)   7.00%cdxs_PercentageOfUndiscountedCashFlowsPerProduct
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
38.00%cdxs_PercentageOfUndiscountedCashFlowsPerProduct
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
 
Percentage of undiscounted cash flows greater than the carrying value of the asset group (percent)   37.00%cdxs_PercentageOfUndiscountedCashFlowsGreaterThanCarryValueOfAssetGroup
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
14.00%cdxs_PercentageOfUndiscountedCashFlowsGreaterThanCarryValueOfAssetGroup
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
 
Fair value in excess of carrying value (percent)   44.00%cdxs_FairValueinExcessofCarryingValuePercentage
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_IntellectualPropertyMember
   
Core Pharmaceutical Business [Member]        
Intangible Assets, Net (Excluding Goodwill) [Abstract]        
Undiscounted cash flows, expected percentage of revenue (percent)     69.00%cdxs_UndiscountedCashFlowCalculationExpectedPercentageOfRevenuePerBusinessRevenueType
/ us-gaap_ProductOrServiceAxis
= cdxs_CorePharmaceuticalBusinessMember
 
Entity-Wide Revenue, Major Customer, Percentage   90.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ProductOrServiceAxis
= cdxs_CorePharmaceuticalBusinessMember
   
Enzyme Opportunities [Member]        
Intangible Assets, Net (Excluding Goodwill) [Abstract]        
Undiscounted cash flows, expected percentage of revenue (percent)     31.00%cdxs_UndiscountedCashFlowCalculationExpectedPercentageOfRevenuePerBusinessRevenueType
/ us-gaap_ProductOrServiceAxis
= cdxs_EnzymeOpportunitiesMember
 
Entity-Wide Revenue, Major Customer, Percentage   10.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ProductOrServiceAxis
= cdxs_EnzymeOpportunitiesMember
   
Money Market Funds [Member]        
Cash, Cash Equivalents and Marketable Securities [Abstract]        
Available-for-sale securities $ 14,602,000us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ cdxs_CashEquivalentsAndMarketableSecuritiesByTypeAxis
= us-gaap_MoneyMarketFundsMember
$ 16,089,000us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ cdxs_CashEquivalentsAndMarketableSecuritiesByTypeAxis
= us-gaap_MoneyMarketFundsMember